- Home
- Companies
- usa new york
- bone marrow
Show results for
Refine by
Bone Marrow Suppliers In Usa New York
9 companies found
based inCranbury, NEW JERSEY (USA)
Advancing an integrated pipeline of genetic therapies that correct the root cause of complex and rare life-threatening childhood disorders. Our mission is to develop first-in-class and best-in-class, curative gene therapies for patients with ...
The LVV platform is ideal for modifying hematopoietic stem cells (HSCs) to address disorders affecting the bone marrow. The LVV transduction process occurs ex vivo (outside the body), which ...
based inRensselaer, NEW YORK (USA)
Taconic Biosciences has been a leading provider of research models for over 65 years. Through all six decades, we've had a singular mission—to accelerate advancements in human health by providing our customers with the best animal model solutions. ...
Origin: Taconic received the NCr nude Spontaneous mutant model from NCI in 1993 after several years of random breeding. The mice were derived by hysterectomy to achieve germ-free status prior to introduction into Restricted Flora™ IBU™ ...
based inHauppauge, NEW YORK (USA)
Busse Hospital Disposables has a proven track record for over 50 years of providing the health care industry with high-quality products and services: All our products are manufactured with strict adherence to industry standards and guidelines. Our ...
Ultra-sharp and manufactured to the highest tolerances, the Busse Bone Marrow Biopsy Needle is designed to provide outstanding and consistent performance. With its substantial, easily gripped handle, our 11g x ...
based inIslandia, NEW YORK (USA)
Crescent Chemical Co., Inc. is a national distributor of Environmental and Analytical reference standards, Karl Fischer reagents and titrators, biochemicals, electrophoresis consumables and instruments, and fine organic and inorganic chemicals. ...
Crescent Chemical Co., Inc. can supply Ultroser G Serum Substitute. Ultroser Gis manufactured by BioSepra in France. Importation of Ultroser G requires a USDA Importation Permit. Crescent Chemical is happy to help you apply for this ...
based inMelbourne, AUSTRALIA
Mesoblast is using its proprietary mesenchymal lineage cell technology platform to develop and commercialize innovative allogeneic cellular medicines to treat complex inflammatory diseases resistant to conventional standard of care. ...
Mesoblast has a strong and extensive global intellectual property (IP) portfolio with protection extending through to at least 2040 in all major markets. This IP position is expected to provide the Company with substantial commercial advantages as ...
based inNew York, NEW YORK (USA)
PAVmed Inc. (Nasdaq:PAVM) is a highly-differentiated, multi-product medical device company employing a unique and proven business model designed to advance products from concept to commercialization much more rapidly and with significantly less ...
The intraosseous route provides a means for infusing fluids, medications, and other substances directly into the bone marrow cavity which communicates with the central venous circulation via nutrient and emissary ...
based inShirley, NEW YORK (USA)
Creative Bioarray is a leading customer-centered biotechnology company and a pioneer with the latest technology of cell patterning. Creative Bioarray has an experienced expert team and is committed to providing comprehensive services and customized ...
CD1 mouse bone marrow neutrophils are derived from the tibias of pathogen-free laboratory adult mice. Each vial contains 10 x10^6 cells and is delivered frozen. Cells are negative for bacteria, yeast, fungi, and ...
based inHaifa, ISRAEL
Pluristem Therapeutics Inc. is a clinical-stage regenerative medicine company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for conditions such as inflammation, muscle injuries, ...
Pluristem’s goal is to provide patients, physicians and healthcare systems around the globe with standardized, easy to use and highly effective PLX cell products that need no genetic or tissue matching prior to administration. We are active ...
based inLondon, UNITED KINGDOM
Hemogenyx Pharmaceuticals is developing breakthrough therapies for the treatment of blood diseases. Hemogenyx Pharmaceuticals plc is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx ...
Originally developed for in-house testing, the company’s Advanced peripheral blood Hematopoietic Chimera (“ApbHC”) is a novel type of humanised mouse that presents several advantages over existing mouse models. It has applications ...